Home/Client Communications/New ALS drug wins approval from the FDA New ALS drug wins approval from the FDA March 8, 2023 Relyvrio was approved by the Food and Drug Administration (FDA) following a clinical trial, making it the first new ALS treatment to receive approval since 2017.
